MARKETSPERPSLIVE44
Cash
Portfolio
TrendingElectionsPoliticsCultureSportsCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive44AccountSocial
Product
Kalshi ProPerpetual FuturesMarketsIncentive programInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
TrendingElectionsPoliticsCultureSportsCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
  1. Medicine

When will the FDA reclassify BPC-157 to Category 1?

Series Image
  1. Medicine

When will the FDA reclassify BPC-157 to Category 1?



Chance

Before September

7%

Before September

7%


Before November

35%

▼ 2
Before November

35%

▼ 2

Before 2027

52%

▼ 6
Before 2027

52%

▼ 6

3 more

Before September

Odds
0% chance
Max payoutSep 1, 2026

$0

$89,364 vol
1D
1W
1M
ALL